Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

High-Altitude blood study aims to improve transplant outcomes

NCT ID NCT07205523

First seen Nov 01, 2025 · Last updated Jun 06, 2026 · Updated 28 times

Summary

This study collects information from 1,000 people receiving stem cell transplants for blood diseases at a hospital on the Qinghai-Tibet Plateau. Researchers track recovery, complications, and costs to learn how high altitude affects treatment. The goal is to build a database that helps doctors provide better care in similar environments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Qinghai University

    RECRUITING

    Xining, Qinghai, 810001, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia aplastic anemia hemophilia A leukemia lymphoma Myelodysplastic Syndromes plasma cell myeloma vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.